MindBio Therapeutics (XCNQ:MBIO) Other Long-Term Liabilities : C$0.31 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Other Long-Term Liabilities?

MindBio Therapeutics's other long-term liabilities for the quarter that ended in Mar. 2024 was C$0.31 Mil.

MindBio Therapeutics's quarterly other long-term liabilities increased from Sep. 2023 (C$0.30 Mil) to Dec. 2023 (C$0.32 Mil) but then declined from Dec. 2023 (C$0.32 Mil) to Mar. 2024 (C$0.31 Mil).

MindBio Therapeutics's annual other long-term liabilities increased from Jun. 2021 (C$0.00 Mil) to Jun. 2022 (C$0.14 Mil) and increased from Jun. 2022 (C$0.14 Mil) to Jun. 2023 (C$0.31 Mil).

MindBio Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for MindBio Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Other Long-Term Liabilities Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Other Long-Term Liabilities

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial					-	-	-	-	-

MindBio Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

MindBio Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.